Skip to content
etf.net

ROM vs TBXU

ProShares Ultra Technology

ROMANYSE Arca

Direxion Daily Biotech Top 5 Bull 2X ETF

TBXUDNYSE Arca

Overlap

Expense ratio

ROM −0.05pt a year

ROM0.93%TBXU0.98%

Avg volume · 30D

ROM 12.8×the volume

ROM47.7KTBXU3.73K

ROM vs TBXU Performance

Oct 31, 2025 – Oct 30, 2026

+26.5%ROM+68.1%TBXU

Oct 31, 2025 to Oct 30, 2026. ROM +26.5%. TBXU +68.1%. Use the arrow keys to read each point.−20%0%40%Oct 2025Apr 2026Oct 2026
Expense ratio
ROM 0.93%, better
TBXU 0.98%
Fund size
ROM $1.15B
TBXU $3M
1Y total return
ROM +26.5%
TBXU +68.1%, better
Yield (12M)
ROM 0.03%
TBXU No data
Holdings
ROM 85
TBXU 11
Avg volume (30D)
ROM 47.7K sh, better
TBXU 3.73K sh
NAV per share
ROM $132.18
TBXU $43.68
52W range

ETF.net Grade

ROM: Cost 70, Risk 56, Mission not scored, Tradability 88, Holdings not scored, Durability 81. TBXU: Cost 29, Risk 65, Mission not scored, Tradability 35, Holdings not scored, Durability 44.
Pillar letters and Scores for ROM, TBXU, with each pillar’s weight
PillarROMTBXU
Cost30% weightA70HigherD29
Mission25% weightNot scoredNot scored
Risk15% weightB56B65Higher
Tradability15% weightA88HigherD35
Holdings10% weightNot scoredNot scored
Durability5% weightA81HigherC44

Rank among Leveraged Long (2x & Other) funds

How we build Categories ›
Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

Same Category. ROM and TBXU are both graded against the same 95 Leveraged Long (2x & Other) funds, so their Grades compare head to head.

Leveraged Long (2x & Other)⁠

Category · 95 funds
See all 95 ›

ROM ranks 3rd and TBXU 70th of 95 funds in the Leveraged Long (2x & Other) Category.

  1. Rank 1AQLDProShares Ultra QQQScore 77
  2. Rank 2AUYGProShares Ultra FinancialsScore 74
  3. Rank 3AROMProShares Ultra TechnologyScore 71
  4. Rank 4BDDMProShares Ultra Dow30Score 69
  5. Rank 37CXWCorgi Ex-U.S. Equities 2x Daily ETFScore 40
  6. Rank 70DTBXUDirexion Daily Biotech Top 5 Bull 2X ETFScore 39
  7. Rank 71DEZJProShares Ultra MSCI JapanScore 38

Our read on each fund

ETF.net Research

ROMAProShares Ultra Technology

TBXUDDirexion Daily Biotech Top 5 Bull 2X ETF

In short

ROM The original 2x tech trade. Since 2007, ROM has aimed at twice the daily move of the S&P 500's technology sector: a double dose in a category now stacked with triples.

TBXU Leveraged biotech, boiled down to five names. TBXU targets 200% of the daily move in an equal-weight basket of the largest US-listed biotechs, at 0.98% net of a waiver through September 1, 2027.

Stated mandate

ROM ROM seeks daily investment results, before fees and expenses, corresponding to twice the daily performance of the S&P Technology Select Sector SM Index.

TBXU The fund seeks daily results equal to 200% of the NYSE Biotechnology Top 5 Equal Weight Index before fees and expenses.

Why people hold it

  • ROM Two times, not three. A 2x daily target means smaller swings and less compounding drag than a 3x fund chasing the same sector.sec.gov
  • Live since January 2007, so it has run through the 2008 crash and the full tech cycle since. Long mileage is rare in geared funds.
  • 0.93% a year, flat, with no waiver propping it up. Peer QLD runs 0.89%, but only net of a waiver through September 30, 2027.
  • One of the strongest implementations in the leveraged-bull pack, from an issuer that has run geared funds since the category's early days.proshares.com
  • TBXU Not a sprawling biotech index: the benchmark holds the top five US-listed biotech stocks, equal weighted, and the fund targets 200% of its daily move.direxion.com
  • Quarterly housekeeping: the index resets to equal weight and swaps in new names if any of the five slip out of the top five by market cap.direxion.com
  • 0.98% net of a waiver through September 1, 2027 (6.27% gross), near the category median for leveraged bull funds and close to ProShares' ROM at 0.93%.

Worth knowing

  • ROM The 2x target resets at each close, so results over weeks or months depend on the path the sector takes, not just where it ends up.sec.govproshares.com
  • Trades thinner than the category's headline names, so spreads and limit orders matter, especially in size.
  • About 80 tech names from the S&P 500. That is one concentrated sector bet, doubled, in both directions.
  • TBXU Daily reset: hold past one day and compounding takes over, so results can drift from 2X the index over that stretch. Direxion says not to expect 2X beyond a day.direxion.com
  • Five stocks, doubled. One failed trial or ugly readout in a single name lands on the whole basket.direxion.com
  • Launched October 2025, still small and thinly traded, which can widen spreads; the 0.98% rests on that waiver through September 1, 2027.

Full ROM profile⁠

Full TBXU profile⁠

ROM vs TBXU Holdings

How we measure overlap

Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.

ROM vs TBXU Cost

Overpaying TBXU vs ROM

$823

On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.

  • ROM 0.93%

    $17,539

  • TBXU 0.98%

    $18,362

$10,000
30 years

Cost over time

  • ROM 0.93%
  • TBXU 0.98%
  • Overpaying
One line per fund, from year 0 to year 30. Use the arrow keys to read each point.$0$5K$10K$15K$20K051015202530TBXU $18,362ROM $17,539

Year by year

YearROMTBXUOverpaying
10$1,644$1,729$85
20$6,199$6,504$305
30$17,539$18,362$823

Expense ratio

  • 0.93%ROM, cheaper
  • 0.98%TBXU
  • Middle half of Leveraged Long (2x & Other) funds
  • Median 0.95%

ROM 29th cheapest of 95 funds

TBXU 71st cheapest of 95 funds

ROM vs TBXU Dividends

Last 12 months to Oct 30, 2026
Yield (12M)
ROM 0.03%
TBXU No data
Payout (12M)
ROM $0.04
TBXU No data
Last payment
ROM $0.02
TBXU $0.14
Ex-dividend
ROM Mar 25, 2026
TBXU Sep 22, 2026
Paid on
ROM Mar 31, 2026
TBXU Sep 29, 2026
Frequency
ROM Quarterly
TBXU Quarterly

Distribution history

Per share, 2017 to 2026, same scale for both

ROMQuarterly · 19 paymentsAll ROM payments⁠
One bar per payment. 19 payments from 2017 to 2026 YTD. Mar 22, 2017 $0.0015; Dec 26, 2017 $0.0075; Mar 21, 2018 $0.0064; Jun 20, 2018 $0.006; Dec 26, 2018 $0.02; Mar 20, 2019 $0.01; Jun 25, 2019 $0.0043; Dec 24, 2019 $0.01; Mar 25, 2020 $0.02; Dec 20, 2023 $0.0042; Mar 20, 2024 $0.01; Jun 26, 2024 $0.04; Sep 25, 2024 $0.06; Dec 23, 2024 $0.03; Mar 26, 2025 $0.02; Jun 25, 2025 $0.14; Sep 24, 2025 $0.05; Dec 24, 2025 $0.02; Mar 25, 2026 $0.02. Use the arrow keys to read each point.$0$0.252017202020232026YTD
TBXUQuarterly · 5 paymentsAll TBXU payments⁠
One bar per payment. 5 payments from 2017 to 2026 YTD. Dec 10, 2025 $0.31; Dec 23, 2025 $0.10; Mar 24, 2026 $0.10; Jun 23, 2026 $0.11; Sep 22, 2026 $0.14. Use the arrow keys to read each point.$0$0.252017202020232026YTD

ROM vs TBXU Risk

Fall from peak · 5 years

This chart needs five years of history for both funds.

Risk facts

VolatilityStd dev, 3 years
ROM 49.3%TBXU 40.6%since Nov 2025
Return per unit of riskSharpe ratio, 3 years
ROM 0.97TBXU 1.39since Nov 2025
Worst fallMax drawdown, 5 years
ROM −67.6%TBXU −26.5%since Oct 2025
Market sensitivityBeta, 5 years
ROM 3.09TBXU −0.18

ROM and TBXU in the news

All news⁠

Popular comparisons

  • ROMAvsQLDA

    ProShares Ultra Technology · ProShares Ultra QQQ

    Expense ratio
    0.93% · 0.89%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • TBXUDvsQLDA

    Direxion Daily Biotech Top 5 Bull 2X ETF · ProShares Ultra QQQ

    Expense ratio
    0.98% · 0.89%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • ROMAvsUYGA

    ProShares Ultra Technology · ProShares Ultra Financials

    Expense ratio
    0.93% · 0.93%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • TBXUDvsUYGA

    Direxion Daily Biotech Top 5 Bull 2X ETF · ProShares Ultra Financials

    Expense ratio
    0.98% · 0.93%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • ROMAvsDDMB

    ProShares Ultra Technology · ProShares Ultra Dow30

    Expense ratio
    0.93% · 0.95%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.

  • TBXUDvsDDMB

    Direxion Daily Biotech Top 5 Bull 2X ETF · ProShares Ultra Dow30

    Expense ratio
    0.98% · 0.95%
    Category
    Same Category. Both funds are graded against the same funds, so their Grades compare head to head.